EUVIMEDAvasta EUVIMED
Open access · CC BY-NC-ND 4.0

Immune Checkpoint Inhibitor Therapy for Orbital and Ocular Adnexal Squamous Cell Carcinomas: International Society of Ocular Oncology President's Lecture, 2022

Bita Esmaeli

Investigative Opthalmology & Visual Science · 2023

DOI: 10.1167/iovs.64.7.29 ↗

At a glance

Journal article in Investigative Opthalmology & Visual Science, 2023. Written by Bita Esmaeli. Institution: Orbital Oncology & Ophthalmic Plastic Surgery, Department of Plastic Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, Unit…. Major MEDLINE topics: Orbital Neoplasms, Conjunctival Neoplasms, Carcinoma, Squamous Cell. Cited 10 times so far (Crossref); 24 references. The full text is freely available (open access, CC BY-NC-ND 4.0).

AbstraktSubjectsBibliograafilised andmedCiteRelated studies

Abstract (original language)

To summarize an invited lecture topic from the proceedings of the International Society of Ocular Oncology meeting in Leiden in 2022. Mechanism of action, indications, and the authors' clinical experience with immune checkpoint inhibitors in patients with locally advanced ocular adnexal squamous cell carcinoma are summarized. Several cases of locally advanced conjunctival, eyelid, and lacrimal sac/duct squamous cell carcinoma that were successfully treated with immune checkpoint inhibitors (PD-1 directed) are shared. Immune checkpoint inhibitors are effective at reducing tumor size and enabling eye-preserving surgery in patients with locally advanced ocular adnexal squamous cell carcinoma with orbital invasion. They present a new strategy for the treatment of locally advanced squamous cell carcinoma of the ocular adnexa and orbit.

Subjects

MeSH terms (MEDLINE)

Orbital NeoplasmsConjunctival NeoplasmsCarcinoma, Squamous CellHumansImmune Checkpoint InhibitorsOrbit

Substances

Immune Checkpoint Inhibitors

Authors and institutions

  • Orbital Oncology & Ophthalmic Plastic Surgery, Department of Plastic Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States.

Cite

APA

Esmaeli, B. (2023). Immune Checkpoint Inhibitor Therapy for Orbital and Ocular Adnexal Squamous Cell Carcinomas: International Society of Ocular Oncology President's Lecture, 2022. Investigative Opthalmology & Visual Science. https://doi.org/10.1167/iovs.64.7.29

Vancouver

Esmaeli B. Immune Checkpoint Inhibitor Therapy for Orbital and Ocular Adnexal Squamous Cell Carcinomas: International Society of Ocular Oncology President's Lecture, 2022. Investigative Opthalmology & Visual Science. 2023. doi:10.1167/iovs.64.7.29

BibTeX
@article{Esmaeli2023,
  author = {Esmaeli, Bita},
  title = {Immune Checkpoint Inhibitor Therapy for Orbital and Ocular Adnexal Squamous Cell Carcinomas: International Society of Ocular Oncology President's Lecture, 2022},
  journal = {Investigative Opthalmology & Visual Science},
  year = {2023},
  doi = {10.1167/iovs.64.7.29}
}
Start for free →